Use + Harm Reduction

Pharmacists May Be Key to Expanding Bupe Access, NIDA Pilot Shows

Collaboration between physicians and pharmacists may boost patients’ satisfaction with, and adherence to, buprenorphine treatment for opioid use disorder (OUD),…

January 13, 2021

Blueberries, Xanny Bars, Clazzys: My Anxiety-Driven Benzo Journey

I have been doing Valium since the age of 16. They were called “blueberries” where I was from, and there…

January 12, 2021

CDC and NIDA Will Finally Study Potential of Safe Consumption Sites

For the first time ever, Congress has weighed in on the issue of safe consumption sites (SCS). A bill tied…

January 7, 2021

NYC Revamps Pharmacies’ Role in Preventing Overdose Deaths

New York City, like the rest of the country, is facing a historic overdose crisis driven by illicit fentanyl adulterating…

January 6, 2021

What Surging Fentanyl Use Among OAT Patients Says About the Pandemic

During the height of the COVID-19 lockdown in Ontario, Canada, the proportion of mandatory, routine drug screens imposed on opioid…

January 5, 2021

DC Decriminalized Drug Paraphernalia. Here’s What That Means on the Ground.

On December 22, District of Columbia Mayor Muriel Bowser (D) signed the Opioid Overdose Treatment and Prevention Omnibus Amendment Act…

January 4, 2021

2020’s Biggest Wins and Losses for Canadians Who Use Drugs

Though 2020 was characterized primarily by the catastrophe of COVID-19, Canada’s public health landscape was marked by significant milestones—both forward…

December 30, 2020

Overdose Survivors’ Top Priorities Are Basic Needs, Research Shows

A new study elevating the voices of opioid users who survived an overdose found that emergency department (ED) healthcare workers…

December 28, 2020

CDC Recommends Drug-Checking Services Amid Historic Overdose Deaths

As the already-staggering death toll of the overdose crisis reaches historic heights, the United States' premier public health agency called…

December 24, 2020

Frontline Harm Reductionists Qualify for Early Vaccination—Will They Get it?

Frontline harm reductionists—including syringe service program (SSP) providers, peer outreach workers and hepatitis C testers—should be eligible for early COVID-19…

December 22, 2020